Evoke Wealth, LLC Zymeworks Inc. Transaction History

Evoke Wealth, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$6.0 - $16.98 $73,074 - $206,799	-12,179 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$39.12 - $54.99 $458,447 - $644,427	-11,719 Reduced 49.04%	12,179 $576,000
Q3 2020 Nov 13, 2020	SELL	$29.21 - $46.58 $698,060 - $1.11 Million	-23,898 Reduced 50.0%	23,898 $1.11 Million
Q2 2020 Aug 10, 2020	BUY	$33.67 - $40.0 $804,645 - $955,920	23,898 Added 100.0%	47,796 $1.72 Million
Q1 2020 May 07, 2020	SELL	$24.28 - $49.8 $242,800 - $498,000	-10,000 Reduced 29.5%	23,898 $848 Million
Q3 2019 Nov 12, 2019	BUY	$22.78 - $29.08 $772,196 - $985,753	33,898 New	33,898 $841 Million

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $949M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Evoke Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Evoke Wealth, LLC with notifications on news.